• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Orchestra BioMed Holdings, Inc.

    Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers OBIO
    Orchestra BioMed to Participate in Jefferies London Healthcare Conference
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers OBIO
    Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers MDT OBIO
    Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board of Directors
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers OBIO
    Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers OBIO
    Orchestra BioMed to Participate in Jefferies Global Healthcare Conference
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers OBIO
    Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers OBIO
    Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers OBIO
    Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers OBIO
    Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers MDT OBIO
    Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers OBIO
    Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers MDT OBIO
    Orchestra BioMed to Participate in Upcoming Investor Conferences
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers OBIO
    Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers OBIO
    Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy for Over 3 Years
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers MDT OBIO
    Orchestra BioMed Reports Third Quarter 2023 Financial Results and Provides Business Update
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers OBIO
    Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for the Treatment of Hypertension in Pacemaker Patients
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers MDT OBIO
    Orchestra BioMed Reports Second Quarter 2023 Financial Results and Provides Business Update
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers OBIO
    Orchestra BioMed™ Granted FDA Approval of IDE for U.S. Pivotal Study of Virtue® Sirolimus AngioInfusion Balloon™ in Patients with Coronary In-Stent Restenosis
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers OBIO
    Orchestra BioMed Set to Join Russell 3000® and other FTSE Russell Indexes
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers OBIO
    Orchestra BioMed Appoints Bill Little as Executive Vice President of Corporate Development and Strategy and Andrew Taylor as Chief Financial Officer
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers MOTS OBIO
    Orchestra BioMed to Present at the Jefferies Global Healthcare Conference
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers OBIO
    Orchestra BioMed Reports First Quarter 2023 Financial Results and Provides Business Update
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers OBIO
    Orchestra BioMed to Present at Upcoming Investor Conferences
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers OBIO
    Orchestra BioMed Strengthens Senior Leadership Team
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Tickers OBIO
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.